A Paragon of Structure Based Drug Design

While Amgen has long been recognized for its strength in developing biologic medicines, our expertise also extends to the field of small molecule drug design. The elegant science applied to a tough cancer target exemplifies this new capability. Learn more at https://Amgenscience.com